On-demand PPI Therapy is Effective on Controlling Symptoms in Patients With Barrett's Esophagus.
NCT04329000 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 218
Last updated 2020-04-03
Summary
On-demand PPI therapy is feasible for the long-term treatment of patients with Barrett's esophagus.
Conditions
- Barrett Esophagus
- Proton Pump Inhibitor
- Symptom
- Reflux
Interventions
- DRUG
-
Esomeprazole 40mg
On-demand Esomeprazole 40 mg QD
- DRUG
-
Esomeprazole
Continuous Esomeprazole 40 mg QD
Sponsors & Collaborators
-
Kaohsiung Veterans General Hospital.
lead OTHER
Principal Investigators
-
SUNG-SHUO KAO, Bachelor · Kaohsiung Veterans General Hospital.
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-02-02
- Primary Completion
- 2019-02-13
- Completion
- 2019-12-08
More Related Trials
-
Does Intensive Acid Suppression Reduce Esophageal Inflammation and Recurrent Barrett's Esophagus Following Ablation?
NCT01093755 ·Status: COMPLETED ·Phase: PHASE4
-
Twenty-Four Hour Combined Multi-Channel Impedance and pH Ambulatory Monitoring: Impedance Reflux Episodes of Patients On and Off Proton Pump Inhibitor Therapy
NCT01710800 ·Status: COMPLETED ·Phase: NA
-
PPI Test in GP Patients
NCT00318084 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Randomized, Double Blind, Double Dummy, Parallel-Group Efficacy Study Comparing 8 Weeks of Treatment With Esomeprazole Magnesium (40mg qd) to Lansoprazole (30mg qd) for the Healing of Erosive Esophagitis in Patients With Moderate or Severe Erosive Esophagitis
NCT00641602 ·Status: COMPLETED ·Phase: PHASE4
-
Reflux Esophagitis Phase III Study (Initial Treatment)
NCT00633932 ·Status: COMPLETED ·Phase: PHASE3
-
Compare D961H 20 mg Bid and 20 mg qd in Patients With Refractory Reflux Esophagitis (Inflammation of Lower Esophagus)
NCT01669811 ·Status: COMPLETED ·Phase: PHASE3
-
Reflux Esophagitis Phase III Study (Maintenance Treatment)
NCT00634114 ·Status: COMPLETED ·Phase: PHASE3
-
Gastric Functions & Proton Pump Inhibitor( PPI) Study
NCT00951431 ·Status: COMPLETED ·Phase: PHASE4
-
JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis
NCT05443984 ·Status: COMPLETED ·Phase: PHASE3
-
Barrett's Esophagus - 315 - 3 Way Cross Over
NCT00637988 ·Status: COMPLETED ·Phase: PHASE4
-
Nexium (Esomeprazole) in Symptom Adapted Therapy in GERD Patients
NCT00444275 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Study of Once-Daily Oral Administration of Esomeprazole 40 mg in Patients With Symptoms of Gastroesophageal Reflux Disease (GERD)
NCT00242736 ·Status: COMPLETED ·Phase: PHASE4
-
Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Comparison of the Remission Rates of Once Daily Treatment With Esomeprazole 20mg and Lansoprazole 15mg for 6 Months in Patients Whose EE Has Been Healed
NCT00644735 ·Status: COMPLETED ·Phase: PHASE4
-
To Assess the Efficacy of Esomeprazole 40 mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
NCT01249651 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.
NCT00206245 ·Status: COMPLETED ·Phase: PHASE2
-
To Assess the Efficacy of Esomeprazole 20mg Once Daily in Subjects Who Still Had Heartburn After Receiving Rabeprazole
NCT01397084 ·Status: COMPLETED ·Phase: PHASE4
-
A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis.
NCT00206284 ·Status: COMPLETED ·Phase: PHASE2
-
Compare Efficacy of Gastric Acid Suppression by Oral and Intravenous Administration of Esomeprazole in Patients With Peptic Ulcer
NCT00471029 ·Status: UNKNOWN ·Phase: PHASE4
-
A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia
NCT00357682 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of LXI-15028 Comparing With Esomeprazole in the Treatment of Erosive Esophagitis
NCT03615677 ·Status: COMPLETED ·Phase: PHASE3
-
A Multicenter, Randomized, Double-Blind Parallel-Group, Placebo-Controlled Efficacy Study Comparing 4 Weeks of Treatment With Esomeprazole 20 mg Once Daily to Placebo qd for the Resolution of Upper Abdominal Pain in Patients With Symptomatic Gastroesophageal Reflux Disease (sGERD)
NCT00626535 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of BLI5100 in Patients With Erosive Esophagitis
NCT05587309 ·Status: COMPLETED ·Phase: PHASE3
-
Esomeprazole for Prevention of Upper Gastrointestinal Symptoms Associated With Continuous Use of NSAIDs
NCT00241514 ·Status: COMPLETED ·Phase: PHASE3
-
APE-Study: Ablation of Barrett's Mucosa vs. Surveillance Without Ablation in Patients Cured From Barrett's Cancer Combined With Randomization of Esomeprazole vs. Placebo for Symptomatic Reflux Control After Successful Barrett's Ablation
NCT00546065 ·Status: TERMINATED ·Phase: NA
-
Nexium Dyspepsia/AST
NCT00251914 ·Status: COMPLETED ·Phase: PHASE3